Journal Home
Search for

Volume 51, Issue 1, Supplement 1, Pages A6-A7 (January 2008)


View previous. 5 of 25 View next.

Article Outline

Suggested Citation

Acknowledgment

Copyright

This 19th Annual Data Report reports data through 2005. The US End-Stage Renal Disease (ESRD) program entered 106,912 patients during 2005, and had 485,012 prevalent patients; 17,429 transplants were performed, and 143,693 patients had functioning grafts at year’s end. Program expenditures reached $32 billion, with $21.3 billion from Medicare accounting for 6.4% of total Medicare expenditures. Incident rates have stabilized at 347 per million, and have fallen for most groups younger than 60, except younger African Americans and Native Americans with diabetic ESRD. Care of the dialysis population continues to improve, with 93% of hemodialysis patients reaching dialysis treatment targets. Fistula use has reached 39% in prevalent patients, with attempted placements doubling since 1996. Analyses of anemia treatment show that overshooting of target hemoglobin levels above 12 g/dL is common, particularly among some providers. While mortality rates continue to fall in the prevalent dialysis population, first-year rates for hemodialysis patients have remained unchanged over the last 9 years, even when adjusted for comorbidity, body mass index, hemoglobin, and estimated glomerular filtration rate. Pediatric patient survival has not changed in the last decade, and children with ESRD appear to be undertreated with growth hormone. Heart failure is a major source of morbidity in the chronic kidney disease, dialysis, and transplant populations. Finally, the public health impact of kidney disease is larger than previously appreciated, particularly in the Medicare/Medicaid dually-enrolled population, and has implications for the budgets of both Medicare and state departments of health, which help care for the disabled and medically indigent.

Suggested Citation 

return to Article Outline

Collins AJ, Kasiske B, Herzog C, et al: Excerpts from the United States Renal Data System 2007 Annual Data Report. Am J Kidney Dis 51:S1–S320, 2008 (suppl 1). Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice:

The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the US government.

Acknowledgements 

return to Article Outline

The staff at the USRDS Coordinating Center is again grateful to the publishers of the American Journal of Kidney Diseases for the opportunity to present the Annual Data Report.

Funding for the USRDS Coordinating Center is provided under contract to the Minneapolis Medical Research Foundation (MMRF; NIH contract HHSN 267 2007 15002C/NO1-DK-7-5002).

PII: S0272-6386(07)01444-8

doi:10.1053/j.ajkd.2007.11.001


View previous. 5 of 25 View next.